Brief: Novo Nordisk Spokesperson Says Pfizer's Claims Against Co's Metsera Offer Is "Without Merit"
03/11/2025 16:54
Nov 3 (Reuters) - Novo Nordisk Spokesperson: NOVO NORDISK SPOKESPERSON: PFIZER’S CLAIMS THAT NOVO NORDISK INTENDS TO SUPPRESS INNOVATION THROUGH OUR OFFER IS "FALSE AND WITHOUT MERIT" NOVO NORDISK SPOKESPERSON: OFFER FOR METSERA HIGHLIGHTS CO’S COMMITMENT TO INVESTING IN THE US Further company coverage: [NOVOb.CO] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metsera
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up